ARCHIVES

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

DeVita: No Decision Yet On FCRF Award

July 17, 1987

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Funding Opporunities: Program Announcments

January 15, 1999

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003